vedolizumab,infliximab
janssen,takeda
[' vedo', 'infliximab', 'inflammatory,bowel', 'vedo', 'vedolizumab']
 study on show again #ecco2023 zhigang liu q
neutralising antibody after 3 dose of sars-cov2 higher speed and rate of breakthrough infection with inflix 
IBD clinician& researcher @IBDHull.Chair:Research Committee of @BritSocGastro . Chair of ECCO CLiNCOM. @NIHR (Y&H ) lead. own views ,RT🚫endorse.⚽️ @LFC fan.